Clinical trial
Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities
NCT02217501 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- January 30, 2020
- Enrollment
- 159 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.